Jie Ni Selected Research

efatutazone

1/2018	Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.
12/2017	PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Ni Research Topics

Disease

28	Neoplasms (Cancer) 06/2022 - 12/2012
15	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 12/2012
13	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2012
8	Inflammation (Inflammations) 05/2021 - 01/2012
6	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2017
5	Atherosclerosis 06/2014 - 04/2013
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 01/2012
4	Diabetic Nephropathies (Diabetic Nephropathy) 03/2012 - 01/2011
4	Peritonitis 01/2010 - 12/2003
3	COVID-19 09/2022 - 01/2021
3	Infections 01/2022 - 01/2021
3	Pathologic Processes 01/2022 - 01/2017
3	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2014
3	Carcinogenesis 01/2021 - 05/2010
3	Hypoxia (Hypoxemia) 01/2021 - 11/2016
3	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2013
3	Fibrosis (Cirrhosis) 01/2018 - 01/2013
3	Adenocarcinoma of Lung 01/2018 - 03/2017
3	Squamous Cell Carcinoma of Head and Neck 05/2015 - 05/2010
2	Circulating Neoplastic Cells 10/2022 - 01/2019
2	IGA Glomerulonephritis (IGA Nephropathy) 06/2022 - 01/2021
2	Triple Negative Breast Neoplasms 01/2021 - 01/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 01/2020
2	Proteinuria 01/2021 - 03/2012
2	Heart Failure 12/2020 - 11/2020
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2020 - 01/2020
2	Pain (Aches) 12/2020 - 12/2013
2	Disease Progression 01/2019 - 01/2016
2	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 01/2016
2	Lymphatic Metastasis 01/2017 - 12/2013
2	Necrosis 05/2015 - 01/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2014 - 04/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2013 - 04/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2013 - 04/2013
2	Dyslipidemias (Dyslipidemia) 07/2013 - 04/2013
2	Body Weight (Weight, Body) 06/2013 - 01/2013
2	Chronic Renal Insufficiency 01/2013 - 03/2012
2	Albuminuria 03/2012 - 03/2011
2	Ischemia 05/2010 - 10/2008
1	Virus Diseases (Viral Diseases) 09/2022
1	Purpura 06/2022
1	Hepatocellular Carcinoma (Hepatoma) 06/2022
1	Insulin Resistance 06/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2003
9	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2016
8	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
7	LipidsIBA 01/2019 - 01/2013
5	LDL Receptors (LDL Receptor)IBA 01/2021 - 01/2012
5	CollagenIBA 01/2021 - 01/2012
5	Gefitinib (Iressa)FDA Link 01/2018 - 01/2017
5	ApolipoproteinsIBA 12/2013 - 01/2013
4	Biological ProductsIBA 06/2022 - 03/2017
4	VaccinesIBA 11/2021 - 04/2013
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2010 - 12/2003
3	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 11/2016
3	Long Noncoding RNAIBA 06/2022 - 10/2018
3	Pharmaceutical PreparationsIBA 01/2022 - 05/2019
3	NucleotidesIBA 01/2022 - 03/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 01/2020
3	Epithelial Cell Adhesion MoleculeIBA 11/2018 - 12/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2003
3	LipopolysaccharidesIBA 01/2016 - 02/2005
3	AntigensIBA 10/2014 - 12/2012
3	hydroxide ionIBA 09/2014 - 01/2014
3	Triglycerides (Triacylglycerol)IBA 12/2013 - 01/2013
3	Apolipoproteins E (ApoE)IBA 12/2013 - 01/2013
3	CholesterolIBA 07/2013 - 01/2013
3	Angiotensin Receptor AntagonistsIBA 01/2013 - 03/2011
3	Irbesartan FDA LinkGeneric 03/2012 - 03/2011
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2010 - 12/2003
2	RNA (Ribonucleic Acid)IBA 09/2022 - 06/2018
2	trans-sodium crocetinate (crocetin)IBA 12/2020 - 11/2020
2	PPAR gammaIBA 01/2018 - 12/2017
2	efatutazoneIBA 01/2018 - 12/2017
2	Therapeutic UsesIBA 01/2018 - 12/2017
2	T0901317IBA 01/2018 - 01/2017
2	Capsules (Microcapsules)IBA 01/2018 - 05/2010
2	Liver X ReceptorsIBA 02/2017 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 02/2016 - 06/2013
2	CytokinesIBA 01/2016 - 03/2012
2	Vitamin D FDA LinkGeneric 09/2014 - 03/2014
2	C-Reactive ProteinIBA 12/2013 - 01/2012
2	SREBP cleavage-activating proteinIBA 12/2013 - 01/2012
2	Caseins (Casein)FDA Link 12/2013 - 07/2013
2	LDL Lipoproteins (beta Lipoproteins)IBA 07/2013 - 01/2013
2	oxidized low density lipoproteinIBA 07/2013 - 01/2013
2	Histone Deacetylase InhibitorsIBA 02/2013 - 01/2013
2	PanobinostatIBA 02/2013 - 01/2013
2	CreatinineIBA 03/2012 - 05/2010
2	Messenger RNA (mRNA)IBA 01/2012 - 01/2011
1	Nucleic AcidsIBA 09/2022
1	Immunoglobulin A (IgA)IBA 06/2022

Therapy/Procedure

18	Therapeutics 06/2022 - 01/2013
11	Radiotherapy 01/2021 - 12/2012
8	Drug Therapy (Chemotherapy) 01/2022 - 12/2012
5	Peritoneal Dialysis 01/2018 - 12/2003
3	Immunotherapy 01/2021 - 04/2013
2	Precision Medicine 01/2022 - 01/2019
2	Castration 01/2014 - 12/2012